Notezine (Diethylcarbamazine Citrate)

Diethylcarbamazine citrate interferes with arachidonic acid metabolism in microfilariae, leading to their immobilisation and death. It also affects adult filarial worms by disrupting their metabolic pathways, thereby reducing parasite viability and aiding in disease control.

The dosage of Notezine is determined by the prescribing clinician based on the patient’s age, weight, infection severity, and local treatment guidelines. Healthcare professionals set the appropriate regimen to ensure efficacy and safety.

Safety data for diethylcarbamazine citrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Notezine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with alternatives such as ivermectin or albendazole, diethylcarbamazine citrate has a distinct mechanism targeting arachidonic acid metabolism, offering rapid microfilarial clearance. Choice of therapy depends on regional parasite species, resistance patterns, and patient‑specific factors.

Notezine should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Notezine is taken orally as directed by a healthcare professional. The tablets are swallowed whole with water, usually on an empty stomach, unless the prescriber advises otherwise. Adherence to the prescribed schedule is essential for optimal therapeutic effect.

Serious adverse events, though rare, include severe allergic reactions such as anaphylaxis, hepatic dysfunction, neutropenia, encephalopathy, severe skin reactions like Stevens‑Johnson syndrome, and cardiac arrhythmias. Immediate medical attention is required if any of these occur.

Notezine is contraindicated in individuals with known hypersensitivity to diethylcarbamazine citrate or any of its excipients. Caution is also advised for patients with severe cardiac disease, uncontrolled hepatic impairment, or those who have experienced serious adverse reactions to similar anthelmintic agents.